
Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER
Combiflex Metformin/Teneligliptin 500mg/20mg extended-release tablets effectively manage elevated blood glucose in patients with type 2 diabetes. This dual-action medication mitigates severe diabetic complications like nephropathy and retinopathy, potentially lowering cardiovascular event risks (heart attack, stroke). Prescribed independently or adjunctively with other antidiabetic therapies, Combiflex achieves optimal efficacy when paired with a balanced diet and consistent exercise. Dosage is individualized, factoring in your health status, glycemic control, and existing medications. Consuming it with food minimizes gastrointestinal distress. Consistent daily dosing maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Maintaining glycemic control prevents future complications, emphasizing adherence to your physician's dietary and exercise plan. Lifestyle modifications are crucial for diabetes management. Common side effects encompass diarrhea, nausea, vomiting, dyspepsia, and cephalgia. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; learn to identify and manage hypoglycemic episodes. This medication isn't universally suitable. Prior to commencing treatment, disclose any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before initiating therapy. Inform your doctor of all current medications to avoid potential drug interactions. Alcohol consumption should be minimized due to its hypoglycemic potential. Your physician will monitor renal function and blood glucose levels throughout the treatment course.
Primary Ingredients of Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER
No text was provided to rewrite.
Uses of Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER
Managing type 2 diabetes
Major Benefits of Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Extended-Release tablets should be administered with a meal.
Common Side effects of Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Genericart Metformin Hydrochloride and Teneligliptin 500mg/20mg Extended-Release tablets should be administered with a meal.
How Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER works:
Metformin and teneligliptin extended-release tablets (500mg/20mg), marketed as Genericart, offer dual-action diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg ER tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release combination of metformin hydrochloride and teneligliptin (500mg/20mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. Prescribing decisions will consider potential benefits against these risks. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metformin Hydrochloride and Teneligliptin 500mg/20mg tablets (Genericart) are likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Extended-Release Tablets on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Metformin Hydrochloride/Teneligliptin 500mg/20mg extended-release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverUNSAFE
The combination medication Metformin Hydrochloride and Teneligliptin (500mg/20mg extended-release tablets) carries a high risk of harm for individuals with hepatic impairment and its use in such patients is strongly discouraged. Medical advice is recommended.
What if you forget to take Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER :
Should you forget a dose of your Genericart Metformin Hydrochloride and Teneligliptin 500mg/20mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Genericart Metformin Hydrochloride+Teneligliptin 500mg/20mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
